Tagged: Non-communicable diseases

  • November 21, 2017

    My tribute to Peter Lamptey’s lifelong contributions to global health

    Written by
    Corey White, Managing Editor, R&E Search for Evidence blog, and Communications Specialist, Research and Evaluation Strategic Initiative, FHI 360

    A version of this post originally appeared on FHI 360’s R&E Search for Evidence blog.

    Known around the world, Prof. Peter Lamptey is a global health champion in any light. Many of you may know him from his early involvement in the global HIV response or from his fight to raise public awareness of noncommunicable diseases (NCDs). I first heard Prof. Lamptey speak about the role of laboratory science in the NCD response at a conference plenary hosted by the African Society for Laboratory Medicine, my former employer. A compelling talk for sure, but notably his plenary was also my first significant introduction to FHI 360’s research.

    Continue reading

  • November 5, 2014

    In Africa, tobacco presents a looming threat to healthy living

    Written by
    Peter Lamptey, Distinguished Scientist and President Emeritus, FHI 360

    In 2013, The Network of African Science Academies, in collaboration with the United States National Academies, convened a committee of 16 diverse experts, including me, to discuss the current state of tobacco use, prevention and control policies in Africa.

    The committee’s findings, recently published in Preventing a Tobacco Epidemic in Africa, were alarming: Without comprehensive tobacco prevention and control policies, smoking prevalence in Africa will increase by nearly 39 percent by 2030, from 15.8 percent in 2010 to 21.9 percent. While tobacco use and tobacco-attributable mortality rates in Africa are currently among the lowest in the world, data indicate that without intervention, this situation will change dramatically for the worse.

    The committee’s report also revealed some startling findings about tobacco as it relates to Africa’s women and youth. Though fewer African women smoke, they are disproportionately affected by tobacco through not only the direct effects of smoking, but also secondhand smoking and the secondary effect of smoking on pregnant women and their fetuses. African youth, meanwhile, represent the largest potential market for tobacco, and levels of smoking in this highly vulnerable population will continue to rise as aggressive tobacco marketing encourages the uptake of smoking. Both women and youth are also targets of covert messaging from the tobacco industry that is designed to mainstream smoking behavior as an element of evolving social norms and empowerment.

    Read the remainder of the blog here.

  • September 15, 2011

    Non-communicable Diseases

    Written by
    Johanna Ralston, Chief Executive Officer, World Heart Federation

    Next week, global leaders will meet at the United Nations to take on some of the world’s greatest killers: cancer, diabetes, chronic respiratory disease, heart disease, and stroke. The UN High-Level Meeting on the Prevention and Control of Non-Communicable Diseases on September 19–20, has the potential to finally address these leading causes of death and disability, which until now have been largely ignored.

    Yet when we wake up on Sept. 21, how much will have changed? Will there be a new Global Fund to fight noncommunicable diseases (NCDs)? Will key stakeholders, such as those involved in urban planning, agriculture, trade and current global health priorities be as engaged as they need to be to realize ambitious goals of measurably reducing disease? Will the public even know what an NCD is — even though more than 60 percent of deaths worldwide are from noncommunicable diseases, the majority from cardiovascular disease?

    ncd_blog_full_article_text_graphic_2011-09-13-02The answer to all of these questions is: not yet. September 21 will be the start of the real work. The problems of NCDs are complex, but we have many opportunities to alter the course of what has become a global crisis.

    There are a number of concrete steps that countries and health systems can take immediately to strengthen their commitment to reducing noncommunicable diseases. They can ratify and implement the Framework Convention on Tobacco Control, the world’s first public health treaty. Many countries already have the makings of NCD plans in existing cancer plans, tobacco control programs and strategies for diabetes and cardiovascular disease. They may also have specific programs to address respiratory disease, mental health and other issues. Health systems can make essential drugs, such as aspirin and statins, available immediately and at a low cost because many are off patent.

    As leading researchers and public health officials said in an April 2011 Lancet article, “An effective response to NCDs requires government leadership and coordination of all relevant sectors and stakeholders, reinforced through international cooperation.”

    In the end, we will need to make compromises and learn to share resources with people and institutions with whom we are not accustomed to collaborating. We will need to delay gratification and risk unpopularity in some of our choices. And we will likely not see the payoff in our lifetimes. But with time, effort and investment, we will see results.

  • July 6, 2011

    Test your NCD Knowledge

    According to the World Health Organization (WHO), non-communicable diseases (NCDs), including cancers, cardiovascular diseases, diabetes, and chronic lung diseases, are responsible for more global deaths every year than all other causes combined. Our new, interactive NCD quiz is a great way for you to test your own knowledge and learn more about how these chronic conditions can affect those living in low- and middle-income countries, as well as how FHI360 is providing solutions.

    Check it out here!